InhaLac®: sieved, milled and micronized alpha-lactose monohydrate for dry powder inhalation.

Administering medication through the pulmonary route is an extremely effective method that comes with multiple benefits, such as rapid action, precise delivery, reduced adverse reactions, and improved patient adherence. Its crucial role in treating respiratory ailments cannot be overstated, and it holds substantial potential for groundbreaking therapies in the future.

Barentz, as part of its USA portfolio, offers InhaLac® MEGGLE's alpha-lactose monohydrate grades for inhalation, which meet all the necessary criteria to achieve the desired quality, safety, and innovation for DPI formulations seamlessly.

InhaLac® is suitable for use in both pulmonary and nasal drug delivery and offers highly controlled powder characteristics: highest microbial quality including low endotoxins, a wide range of particle sizes, customized grades, and customized product specifications.

High quality crystalline lactose, designed for dry powder inhaler.

InhaLac® from MEGGLE.

InhaLac® grades of lactose are suitable for use in pulmonary and nasal drug delivery.

Inhalation aerosols offers the potential for needle-free systemic delivery of small molecule drugs as well as therapeutic peptides and proteins. An industry standard in dry powder inhalation formulation development, lactose monohydrate is used safely in DPI formulations. Using lactose as an excipient not only improves performance efficiency of the inhaler, but also facilitates powder handling during production. Effective performance of a dry powder inhaler largely depends on the carrier material used for the drug formulation.

With MEGGLE's controlled production process different high quality grades for inhalation are obtained, providing an adequate range of particle sizes - making them behaves as individual particles.

Request a sample!

Discover the InhaLac® broad range

Click here!